MDLN Analyst Ratings & Price Targets

MDLNMDLN

|||

Overview News Fundamentals Key Metrics TTM Financials Earnings Growth Rating Analysts Institutional Peers Historical

No analyst ratings available

Price Target Expectations

Analysts see modest upside — consensus target 6% higher.

Bear Case

$38.00

-14%

Consensus

$46.85

+6%

Bull Case

$52.00

+18%

Price Range0 analysts

Low

Consensus

High

$38.00

$52.00

Current Target

Current Price

$44.12

Upside to Target

$2.73

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

2026E$1.48(15 analysts)

P/E52x

Current: 52.2x

Actual

Estimate

Range (Low–High)

Stock Alarm Pro

Forward Growth Estimates (YoY)

FY2027

Rev+7.55%

EPS-13.06%

FY2028

Rev+7.83%

EPS+6.94%

Earnings Surprises

Earnings surprise history unavailable.

Recent Analyst Actions

Jan 12, 2026Barclays

Medline initiated with an Overweight at Barclays

Target:$50.00

+20.0%from $41.65

Jan 12, 2026BNP Paribas

Medline initiated with a Neutral at BNP Paribas

Target:$38.00

-9.9%from $42.19

Jan 12, 2026Wolfe Research

Medline initiated with an Outperform at Wolfe Research

Target:$47.00

+12.2%from $41.88

Jan 12, 2026Deutsche Bank

Medline initiated with a Hold at Deutsche Bank

Target:$40.00

-1.3%from $40.52

Jan 12, 2026Wells Fargo

Medline initiated with an Equal Weight at Wells Fargo

Target:$42.00

+3.7%from $40.52

Jan 12, 2026BTIG

Medline initiated with a Buy at BTIG

Target:$50.00

+23.4%from $40.52

Jan 12, 2026Mizuho Securities

Medline initiated with an Outperform at Mizuho

Target:$48.00

+18.5%from $40.52

Jan 12, 2026UBS

Medline initiated with a Buy at UBS

Target:$48.00

+18.5%from $40.52

Jan 12, 2026Stifel Nicolaus

Medline initiated with a Buy at Stifel

Target:$46.00

+13.5%from $40.52

Jan 12, 2026Redburn Partners

Medline initiated with a Neutral at Rothschild & Co Redburn

Target:$42.00

+3.7%from $40.52

Jan 12, 2026Leerink Partners

Medline initiated with an Outperform at Leerink

Target:$48.00

+18.5%from $40.52

Jan 12, 2026Evercore ISI

Medline initiated with an Outperform at Evercore ISI

Target:$50.00

+23.4%from $40.52

Jan 12, 2026Bernstein

Medline initiated with an Outperform at Bernstein

Target:$49.00

+20.9%from $40.52

Jan 12, 2026Truist Financial

Medline initiated with a Buy at Truist

Target:$52.00

+28.3%from $40.52

Jan 12, 2026Piper Sandler

Medline initiated with an Overweight at Piper Sandler

Target:$50.00

+23.4%from $40.52

Jan 12, 2026Robert W. Baird

Medline initiated with an Outperform at Baird

Target:$48.00

+18.5%from $40.52

Jan 12, 2026BMO Capital

Medline initiated with an Outperform at BMO Capital

Target:$45.00

+11.1%from $40.52

Jan 12, 2026Goldman Sachs

Goldman Sachs Starts Medline Inc (MDLN) at Buy

Target:$49.00

+20.9%from $40.52

Jan 12, 2026RBC Capital

Medline initiated with an Outperform at RBC Capital

Target:$47.00

+16.0%from $40.52

Jan 11, 2026Morgan Stanley

Medline initiated with an Overweight at Morgan Stanley

Target:$48.00

+18.5%from $40.52

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance